Zobrazeno 1 - 10
of 40
pro vyhledávání: '"T. F. Schaible"'
Publikováno v:
Inflammatory Bowel Diseases. 8:237-243
Objective The aim of this study was to assess the effect of infliximab on quality of life in patients with active Crohn's disease (CD) inadequately responsive to concomitant therapies. Methods We examined responses to the Inflammatory Bowel Disease Q
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd2af494c7610707377af4c2e5aa439f
https://doi.org/10.1097/00054725-200207000-00001
https://doi.org/10.1097/00054725-200207000-00001
Autor:
S. J. H. Van Deventer, Paul Rutgeerts, C Kothe, Karel Geboes, R. A. van Hogezand, F Baert, DM Chalmers, T. F. Schaible, Geert D'Haens, T. Braakman
Publikováno v:
Gastroenterology, 116(5), 1029-1034. W.B. Saunders Ltd
Background & Aims: Tumor necrosis factor (TNF) is a pivotal cytokine in intestinal inflammation. Controlled trials using a chimeric anti-TNF antibody (infliximab) have shown its efficacy in refractory Crohn's disease. Methods: Endoscopic and histolog
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84990064c3c03435f4fcb979c15bad15
https://doi.org/10.1016/s0016-5085(99)70005-3
https://doi.org/10.1016/s0016-5085(99)70005-3
Autor:
K. L. Dewoody, T. F. Schaible, Stephan R. Targan, S. J. H. Van Deventer, T. Braakman, Stephen B. Hanauer, Paul Rutgeerts, Daniel H. Present, Lloyd Mayer
Publikováno v:
The New England journal of medicine, 337, 1029-1035. Massachussetts Medical Society
Background Studies in animals and an open-label trial have suggested a role for antibodies to tumor necrosis factor alpha, specifically chimeric monoclonal antibody cA2, in the treatment of Crohn's disease. Methods We conducted a 12-week multicenter,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c37d1fc27af96e76e0059277982b305f
https://doi.org/10.1056/nejm199710093371502
https://doi.org/10.1056/nejm199710093371502
Publikováno v:
PerinatalMedizin. 8:40-43
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3b32490f62e7c469a21f03586e25af75
https://doi.org/10.1007/s001520050011
https://doi.org/10.1007/s001520050011
Autor:
Wolfgang Rutsch, D de Bono, Gr. Heyndrickx, J. C. A. Hoorntje, M. L. Simoons, M. J. De Boer, T F Schaible, L R van der Wieken, M. van den Brand, A. J. M. Van Miltenburg
Publikováno v:
Circulation. 89:596-603
BACKGROUND Patients with unstable angina despite intensive medical therapy, ie, refractory angina, are at high risk for developing thrombotic complications: myocardial infarction or coronary occlusion during percutaneous transluminal coronary angiopl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::448628603877911abb70135fe411378b
https://doi.org/10.1161/01.cir.89.2.596
https://doi.org/10.1161/01.cir.89.2.596
Autor:
T F Schaible, Mark A. Kelley, S Meranze, H J Berger, J Brown, Harold I. Palevsky, Naresh C. Gupta, Abass Alavi, Allison D. Jatlow
Publikováno v:
Radiology. 175:79-85
The recent development of monoclonal antibodies against components of coagulated blood may provide new approaches to the diagnosis of venous thrombosis. Scanning with an indium-111-labeled Fab fragment of a murine monoclonal antifibrin antibody (59D8
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad85cab9a86209be54eef05fc0f62f9e
https://doi.org/10.1148/radiology.175.1.2315506
https://doi.org/10.1148/radiology.175.1.2315506
Autor:
T F, Schaible
Publikováno v:
Presse medicale (Paris, France : 1983). 30(12)
INFLIXIMAB: Is a chimeric antitumour necrosis factor-alpha monoclonal antibody that has been studied for the treatment of Crohn's disease and rheumatoid arthritis. A LONG TERM SAFETY: In several placebo controlled, randomized clinical trials and open
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::cb65cf1f461ebcb092465a2139642f96
https://pubmed.ncbi.nlm.nih.gov/11317923
https://pubmed.ncbi.nlm.nih.gov/11317923
Autor:
H M, Lorenz, M, Grünke, T, Hieronymus, C, Antoni, H, Nüsslein, T F, Schaible, B, Manger, J R, Kalden
Publikováno v:
The Journal of rheumatology. 27(2)
To investigate the longterm consequences of tumor necrosis factor-alpha (TNF-alpha) blockade in patients with rheumatoid arthritis (RA), to compare changes after repeated infusion of cA2 monoclonal antibody with those occurring after the initial trea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::83ebdd4b9371305060d8d54fef893486
https://pubmed.ncbi.nlm.nih.gov/10685789
https://pubmed.ncbi.nlm.nih.gov/10685789
Publikováno v:
The International journal of artificial organs. 22(11)
The aim of the study is to investigate which of two treatment options of saline lavage induced ARDS in rabbits is better in terms of oxygenation and prevention of barotrauma: combined high peak pressure ventilation with surfactant administration and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f9e923a962df21ec403a0c33a6350e15
https://pubmed.ncbi.nlm.nih.gov/10612302
https://pubmed.ncbi.nlm.nih.gov/10612302
Autor:
T. F. Schaible, K. L. Dewoody, R. A. van Hogezand, Eric A. Vasiliauskas, Stephan R. Targan, T. Braakman, Stephen B. Hanauer, Paul Rutgeerts, S.H.J. van Deventer, Geert D'Haens, L Mayer, D H Present
Publikováno v:
Gastroenterology, 117(4), 761-769. W.B. Saunders Ltd
Infliximab, an anti-tumor necrosis factor monoclonal antibody, rapidly reduces signs and symptoms of active Crohn's disease. The aim of this study was to determine whether repeated infusions of infliximab would effectively and safely maintain the rem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96eca7694cba206d888183a7af53fa0e
https://pubmed.ncbi.nlm.nih.gov/10500056
https://pubmed.ncbi.nlm.nih.gov/10500056